Cite
HARVARD Citation
Hebbar, M. et al. (n.d.). 2305 Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part. European journal of cancer. pp. S434-. [Online].